
PathAI
AI pathology platform for cancer diagnosis and biomarker analysis Pricing: Paid. See pros, cons, alternatives, and comparisons.
- Always free
- No credit card
What is PathAI?
Key features
Cancer detection and classification
identifies malignant tissue and categorises cancer types from pathology images
Biomarker analysis
predicts relevant molecular and immunological markers that guide treatment selection
Whole-slide image processing
handles large, high-resolution digital pathology scans
Diagnostic support
provides AI-generated findings to assist pathologist decision-making
Clinical workflow integration
connects with laboratory information systems and digital slide archives
Pros & cons
Advantages
- Helps standardise diagnostic interpretation across different pathologists and institutions
- Can improve turnaround time for pathology results in high-volume settings
- Identifies biomarkers relevant to precision medicine and targeted therapies
- Reduces cognitive load by automating preliminary image analysis
Limitations
- Requires digital pathology infrastructure and whole-slide scanning capability, which not all labs possess
- AI predictions still require pathologist validation; cannot replace human expertise entirely
- Integration with existing laboratory workflows may require technical support and staff training
Use cases
Cancer diagnosis support in hospital and diagnostic laboratory pathology departments
Biomarker prediction to inform oncology treatment planning
Clinical trial pathology analysis where consistency across sites is important
Research applications studying cancer histopathology patterns
Ready to try PathAI?
Pricing
Contact for pricing
Paid (pricing not publicly listed)
Access to PathAI platform; pricing varies based on institutional size, usage volume, and specific modules required
Get started with PathAI
Click through to PathAI and start using it now.
- Always free
- No credit card